Clofazimine does not lead to significant QT interval prolongation: a multicentre study

Zweijpfenning, S.M.H. (Sanne M H), van Groningen, H. (Hester), J. van Ingen (Jakko), C. Magis-Escurra (Cecile), M. Boeree (Martin), D. Wagner (Dirk), H.I. Bax (Hannelore), Andrejak, C. (Claire), Wener, R. (Reinier), Rahman, A. (Ananna), et al. Hoefsloot, W. (Wouter)

2018-11-01

Additional Metadata
Persistent URL	doi.org/10.1183/13993003.01386-2018, hdl.handle.net/1765/111895
Journal	The European Respiratory Journal
Rights	no subscription
Organisation	Department of Internal Medicine
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Zweijpfenning, S.M.H. (Sanne M H), van Groningen, H. (Hester), van Ingen, J., Magis-Escurra, C., Boeree, M., Wagner, D., Bax, H., Andrejak, C. (Claire), Wener, R. (Reinier), Rahman, A. (Ananna), Kunst, H. (Heinke), Lorent, N. (Natalie), Brouwer, M.A. (Marc A.)& Hoefsloot, W. (Wouter). (2018). Clofazimine does not lead to significant QT interval prolongation: a multicentre study. The European Respiratory Journal, 52(5).https://doi.org/10.1183/13993003.01386-2018

Publication